Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting type I diabetes.

A G Ziegler1, R D Herskowitz, R A Jackson

  • 1Joslin Diabetes Center, Brigham and Women's Hospital, New England Deaconess Hospital, Boston, MA 02215.

Diabetes Care
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives.

Molecular metabolism·2016
Same author

Development of a simple tool to predict the risk of postpartum diabetes in women with gestational diabetes mellitus.

Acta diabetologica·2015
Same author

Immunogenetics of endocrine disorders.

Immunology today·2014
Same author

Synapse selection based on differences in synapse turnover.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014
Same author

Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes.

International journal of obesity (2005)·2014
Same author

Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes.

Diabetologia·2013
Same journal

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

Diabetes care·2026
Same journal

Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.

Diabetes care·2026
Same journal

Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.

Diabetes care·2026
Same journal

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

Diabetes care·2026
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
See all related articles

Predicting type 1 diabetes is possible in relatives using three key markers: islet cell antibodies, insulin autoantibodies, and impaired insulin release. This allows for early identification of individuals at high risk for developing autoimmune diabetes.

Area of Science:

  • Endocrinology
  • Immunology
  • Diabetes Research

Background:

  • Type 1 diabetes results from autoimmune destruction of pancreatic beta cells.
  • Early prediction of type 1 diabetes is crucial for intervention and prevention strategies.
  • Identifying susceptible individuals allows for targeted research and clinical trials.

Purpose of the Study:

  • To evaluate the predictive value of specific biomarkers for type 1 diabetes development.
  • To identify first-degree relatives at high risk of developing type 1 diabetes within a 10-year timeframe.
  • To enable future trials for diabetes prevention and assess the impact of prediction on morbidity and mortality.

Main Methods:

  • Assessing high-titer cytoplasmic islet cell antibodies.
  • Measuring insulin autoantibodies using fluid-phase radiobinding assays.

Related Experiment Videos

  • Evaluating first-phase insulin release after intravenous glucose challenge (less than 1st percentile).

    • Main Results:

    • A combination of the three markers demonstrates high positive predictive value.
    • It is possible to identify first-degree relatives with a high probability of developing type 1 diabetes.
    • Prediction is feasible within a limited time span (less than 10 years).

    Conclusions:

    • The studied markers can effectively predict type 1 diabetes in susceptible relatives.
    • Early prediction facilitates the design of prevention trials.
    • Predictive capabilities can inform strategies to reduce morbidity and mortality associated with type 1 diabetes onset.